Lansforsakringar Fondforvaltning AB (publ)
Position in IDXX — Idexx Laboratories Inc /De
CIK 2059323
Stockholm, V7
Position in IDXX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$12,719,316
-$1,848,806 QoQ
Shares Held
24,161
-6.8% QoQ
Ownership
0.031%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#251
of 1,286 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IDXX Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Lansforsakringar Fondforvaltning AB (publ) holds $191,892,065 across 12 Diagnostics & Research names. IDXX ranks #3 (6.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
131,916 | $66,137,405 | |
| 2 | DHR |
Danaher Corp /De/
|
196,388 | $37,407,986 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
This page
|
24,161 | $12,719,316 | |
| 4 | A |
Agilent Technologies, Inc.
|
88,456 | $11,749,610 | |
| 5 | WAT |
Waters Corp /De/
|
30,952 | $11,608,238 | |
| 6 | NTRA |
Natera, Inc.
|
40,580 | $11,015,441 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
51,226 | $9,897,887 | |
| 8 | MTD |
Mettler Toledo International Inc/
|
6,414 | $8,193,949 |
All Filings in IDXX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,719,316 | 24,161 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $14,568,122 | 25,927 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $17,844,155 | 26,376 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $16,904,390 | 26,459 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $13,674,524 | 25,496 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $11,355,867 | 27,041 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $11,225,722 | 27,152 | Shares | Sole | 2025-03-14 | |
| No filing history on record for this holder in this stock. | ||||||